|
Company:
|
AXOGEN, INC. (AXGN)
|
|
Form Type:
|
8-K
|
|
Filing Date:
|
7/11/2013
|
|
CIK:
|
0000805928
|
|
Address:
|
13631 PROGRESS BLVD.
SUITE 400
|
|
City, State, Zip:
|
ALACHUA, Florida 32615
|
|
Telephone:
|
(386) 462-6817
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$15.85
|
Change:
0.15 (0.96%)
|
Trade Time:
01:01 PM EST
|
Market Cap:
$526.86M
|
|
|
|
|
|
|
Description of Business
|
|
We are a global leader in innovative surgical solutions for peripheral nerve
injuries. We provide products and education to improve surgical treatment
algorithms for peripheral nerve injuries. Our portfolio of products includes
Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for
bridging severed nerves without the comorbidities associated with a second
surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular
matrix ("ECM") coaptation aid for tensionless repair of severed nerves,
AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and
protect injured peripheral nerves and reinforce the nerve reconstruction while
preventing soft tissue attachments and AviveTM Soft Tissue Membrane, a minimally
processed human umbilical cord membrane that may be used as a resorbable soft
tissue covering to separate tissues and modulate inflammation in the surgical
bed.
|
|
|
|